Stockreport

Kazia Therapeutics up 18% premarket on positive paxalisib data [Seeking Alpha]

Kazia Therapeutics Limited - American Depositary Shares  (KZIA) 
US:NASDAQ Investor Relations: kaziatherapeutics.com
PDF Ultra-thinly traded nano cap Kazia Therapeutics (NASDAQ:KZIA18%interim dataPhase 2 clinical trialAt data cutoff, median overall survival was 17.7 months compared to 12.7 [Read more]